Data indicate that inflation is easing. Add to that, the Inflation Reduction Act, which passed last year, allows Medicare to negotiate prices on some popular drugs with pharmaceutical companies. That could be a long-term positive for seniors, but pharma prices are heading higher, and that could be a benefit to a variety of exchange traded [...] The post Rising Pharma Prices Could Give a Beat to HART ETF appeared first on ETF Trends .